Trypanosoma brucei genomics and the challenge of identifying drug and vaccine targets.

E.C. Agbo, P.A.O. Majiwa, P. Buscher, E. Claassen, M.F.W. te Pas

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)


There have been tremendous advances in our knowledge of trypanosome biology, yet many aspects remain unclear. Currently, the genome of Trypanosome brucei is being sequenced and this, with other genome-wide analysis methods, could provide novel insights into the parasite and facilitate the development of effective controls. An important new challenge investigators face is how to exploit the information in studying a parasite with so many genetic peculiarities. Here, we summarize our current understanding of molecular genetics of T. brucei and attempt to link genome analysis to the prospects for identifying possible targets for vaccines, novel drugs and specific diagnostics. The value of newly developed genotyping approaches in accelerating these processes is discussed.
Original languageEnglish
Pages (from-to)322-329
JournalTrends in Microbiology
Issue number7
Publication statusPublished - 2003


  • haptoglobin-related protein
  • kinetoplast dna network
  • expressed sequence tags
  • rna interference
  • african trypanosomes
  • sleeping-sickness
  • human-serum
  • plasmodium-falciparum
  • surface-proteins
  • gene-expression


Dive into the research topics of 'Trypanosoma brucei genomics and the challenge of identifying drug and vaccine targets.'. Together they form a unique fingerprint.

Cite this